November 25, 2015


Azur Spa rebrands to RE Salons and Spas, with ambitious roll-out plan and exciting new investment partnership

Dubai’s award-winning wellness brand, Azur Spa, has undergone a strategic rebrand to become RE Salons and Spas. The new brand identity reflects RE's holistic approach, and signals the start of the company’s expansion plans. As part of the new direction, Azur Spa founder, Partner and Chief Wellness Advocate Rana El-Eid has signed a partnership deal with Luminar Investment LTD, a UAE-based business group. This alliance aims to harness the buoyant beauty and spa sector to create further opportunity for growth through"...

Continue Reading >

November 25, 2015


Towards the creation of cattle vaccine bank in North Africa

International donors have agreed in principle on the creation of a vaccine bank for livestock in the North Africa region, have indicated Tuesday in Algiers, members of the Joint Standing Committee of the Mediterranean animal health network.

At their meeting attended by Minister of Agriculture, Rural Development and Fisheries Sid Ahmed Ferroukhi, the delegates of the"...

Continue Reading >

November 22, 2015


U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the U.S. Food and Drug Administration (FDA) has approved NINLARO® (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill. More information is available at


Continue Reading >

November 21, 2015


The Estée Lauder Companies Names John Demsey Executive Group President; Jane Hertzmark Hudis Promoted to Group President

The Estée Lauder Companies Inc. (NYSE:EL) today announced the following executive appointments, effective January 1, 2016:

  • John Demsey will expand his responsibilities and become Executive Group President, The Estée Lauder Companies. Mr. Demsey will add Clinique and the Men’s Skincare Group to his portfolio while continuing to oversee Aramis and Designer Fragrances, Prescriptives, M•A•C Cosmetics (“M•A•C”), Bobbi Brown, Jo Malone London, Bumble and"......

    Continue Reading >

November 20, 2015


Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union

  • Samsung Bioepis’ Benepali® becomes the first-ever etanercept biosimilar to meet the European Medicines Agency’s requirements on the quality, efficacy and safety of biosimilars
  • If a marketing authorization is granted by the European Commission, Benepali® will be the first etanercept biosimilar to be approved in the European Union

Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s"...

Continue Reading >

November 19, 2015


Merck launches production of its anti-diabetes medicine in Algeria

Merck (, a leading science and technology company, today announced the commissioning of its medicine production unit for the treatment of both diabetes and high blood pressure. A joint venture project has subsequently been set up between the company and its partner, the Algerian laboratory Novapharm.


Continue Reading >

November 19, 2015


New Survey Showed GI Health and Anti-Aging Benefits of Morinaga's Probiotics Milk with BB536

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), Japanese leading dairy product company, today unveiled the results of a nationwide survey jointly conducted with Tokyo Healthcare University in Japan on the health status of over 20,000 middle-aged to elderly men and women for the purpose of investigating the relationship between regular consumption of calcium-fortified milk containing Bifidobacterium longum BB536 and health status.


Continue Reading >

November 18, 2015


Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma

  • Breakthrough Therapy designation highlights the potential of avelumab* as a new immunotherapy for patients with metastatic Merkel cell carcinoma (MCC)
  • Metastatic MCC is a devastating disease and if approved, avelumab could potentially become the first immunotherapy to treat metastatic MCC

Merck and Pfizer today announced that the US Food and Drug Administration (FDA) has granted avelumab*, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough Therapy designation for the"...

Continue Reading >

November 17, 2015


Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance

W. L. Gore & Associates, Inc. (Gore) today announced in conjunction with its 40th anniversary, it has sold 40 million devices worldwide. The milestones come as the company showcases its latest innovations and achievements for the vascular community at the 2015 VEITHsymposium® in New York.

The medical products division of Gore was formed by Bill Gore with the intent to design an ideal substitute for"......

Continue Reading >

November 17, 2015


GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide

W. L. Gore & Associates, Inc. (Gore) today announced that the GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe. The device is currently commercially"......

Continue Reading >

Forex Market Video